Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 530 of 6351
-
Could a common asthma drug shorten bronchiolitis hospital stays?
Disease control Recruiting nowThis study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms
Phase 2 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for deadliest breast cancer complication: drug combo trial launches
Disease control Recruiting nowLeptomeningeal metastases (LM) is a lethal complication of malignant tumors, characterized by tumor cell invasion and proliferation within the subarachnoid space. LM from HER2-negative breast cancer remains challenging to treat, with a median overall survival of only 3-6 months d…
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
AI ultrasound could revolutionize childhood cancer diagnosis
Diagnosis OngoingThe goal of this observational study is to build an intelligent ultrasound diagnostic system that integrates pathological typing, risk stratification and prognosis assessment. The main question it aims to answer is: 1. Can the prediction model of neuroblastoma tumors (NTs) in ch…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells aim to deepen remission in lymphoma patients
Disease control Recruiting nowThe purpose of this study is to determine the efficacy and safety of CD19/CD22 Chimeric Antigen Receptor (CAR) T-Cell immunotherapy as first-line consolidation therapy in patients with follicular lymphoma.
Phase 2 • Sponsor: Liping Dou • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
AI reads skin biopsies to spot hidden lymphomas
Diagnosis OngoingCutaneous lymphoproliferative diseases (CLPDs) are a group of skin disorders that range from benign conditions, such as pseudolymphomas, to malignant forms like cutaneous T-cell and B-cell lymphomas. Mycosis fungoides is the most common malignant type, but diagnosis is often diff…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
AI reads eye scans to spot thyroid disease activity and severity
Diagnosis Recruiting nowThe goal of this observational study is to prospectively validate the efficacy of an AI multimodal model constructed based on multi - sequence orbital MRI in the diagnosis, activity and severity assessment, and prognosis prediction of thyroid - associated ophthalmopathy (TAO) in …
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Doctors handing out screening kits could prevent colon cancer
Prevention Not yet recruitingIn this registry-based cluster randomized controlled trial, we will assess the impact of a proactive strategy of general practitioners (GP) who will systematically provide screening kits of colorectal cancer (CRC) to all patients of even age (50, 52, 54...up to 74 years) versus u…
Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 26, 2026 15:36 UTC
-
Engineered immune cells take on lupus and scleroderma in new trial
Disease control Recruiting nowCAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a pneumonia vaccine protect the most vulnerable children?
Vaccine Not yet recruitingThe goal of the OPTIMAL clinical trial is to learn if a dose of a pneumococcal conjugate vaccine (PCV) generates a good immune response in young children who are in hospital with severe acute malnutrition. Researchers will compare an intervention group who get a dose of a PCV (P…
Phase 4 • Sponsor: Nick Fancourt • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC
-
Gout drug may halt dangerous seizure clusters in epilepsy patients
Disease control Not yet recruitingProbCluster trial aims at making the proof of concept of antiseizure efficacy of the old antigout PBN in SC, in which Panx1 involvement is relevant on SC pathophysiology and in which efficient therapies are still lacking. The trial will be performed on patients with focal epileps…
Phase 2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail offers hope for Hard-to-Treat head and neck cancer
Disease control Not yet recruitingThis study is a single-arm Phase II trial designed to evaluate the efficacy and safety of Docetaxel, Nimotuzumab, and Pucotenlimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma who have failed prior PD-1/PD-L1 inhibitor and pla…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo aims to speed blood recovery in cancer transplants
Disease control Recruiting nowAutologous hematopoietic stem cell transplantation(auto-HSCT) plays an important role in treating hematologic malignancies. Mobilization and collection of peripheral blood stem/progenitor cells is the key to successful autologous hematopoietic stem cell transplantation. Currently…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New program aims to close the 'Deadly Gap' for veterans leaving service
Disease control Recruiting nowBackground Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cord blood transplant offers new hope for rare EBV diseases
Disease control Recruiting nowThis clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilical cord blood transplantation group to evaluate the efficacy and safety of unrelated umbilical cord blood transplantatio…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could cutting one amino acid help fight stomach cancer?
Disease control Recruiting nowBased on existing literature, we posit that a leucine-restricted diet is safe and well-tolerated in patients with advanced gastric cancer receiving combined chemotherapy and immunotherapy. Patients adhering to this dietary regimen exhibit a significant reduction in serum leucine …
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Stem cell showdown: donor or self? new trial aims to improve lymphoma outcomes
Disease control Recruiting nowThis study is a multicenter, two-arm, prospective clinical trial, comprising two groups: the allogeneic hematopoietic stem cell transplantation group (Allo-HSCT) and the autologous hematopoietic stem cell transplantation group (Auto-HSCT). It aims to evaluate the efficacy and saf…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Triple-threat treatment aims to make inoperable lung cancer removable
Disease control Recruiting nowThis is a Phase II clinical trial evaluating the efficacy and safety of a new treatment approach for patients with locally advanced non-small cell lung cancer (NSCLC) that has spread to lymph nodes on the opposite side of the chest (known as N3 lymph node involvement). The study…
Phase 2 • Sponsor: Yang Hong • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo therapy offers hope for hard-to-treat lymphoma patients
Disease control Not yet recruitingFor relapsed/refractory mantle cell lymphoma patients that previously treated with BTK inhibitors: The first part involves 6 cycles of combined therapy with zuberitamab, selinexor, dexamethasone, and thalidomide. This targeted combination regimen can enhance efficacy while reduci…
Phase 4 • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo aims to fight colorectal cancer when standard chemo fails
Disease control Not yet recruitingFruquintinib, as a standard treatment for refractory metastatic colorectal cancer (mCRC), has attracted increasing research efforts to explore its innovative strategies in combination with chemotherapy. Trifluridine/tipiracil plus bevacizumab is also a standard treatment for mCRC…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New cell therapy offers hope for Hard-to-Treat lymphoma patients
Disease control Not yet recruitingEvaluate the safety and tolerability of AcNK-Sup003 cell injection in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). To preliminarily determine the Maximum Tolerated Dose (MTD) or recommended clinical dose of AcNK-Sup003 cell injection.
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC